tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Premier Health of America Reports Q3 2025 Results Amidst Operational Shifts

Story Highlights
  • Premier Health reported a decline in revenue and adjusted EBITDA due to reduced volumes.
  • The company focuses on cost reduction and operational efficiency amidst challenges.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Premier Health of America Reports Q3 2025 Results Amidst Operational Shifts

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Premier Health of America Inc ( (TSE:PHA) ) is now available.

Premier Health of America Inc. reported its third-quarter results for 2025, highlighting a significant decline in revenue and adjusted EBITDA compared to the previous year, primarily due to reduced volumes in Quebec and British Columbia. The company’s net loss decreased, aided by favorable fair value adjustments and lower income tax. The implementation of Quebec’s Bill 10 continued to impact the Per Diem segment, which now accounts for only 4% of revenues. Despite challenges, the company is focusing on cost reduction, debt management, and operational efficiency, with plans to shift focus to Travel Nurses and explore opportunities in the Home Care sector.

Spark’s Take on TSE:PHA Stock

According to Spark, TipRanks’ AI Analyst, TSE:PHA is a Neutral.

Premier Health of America Inc is currently facing severe financial difficulties, as reflected in its financial performance score. The technical analysis indicates a bearish trend, and the valuation is poor due to negative profitability. These factors significantly impact the overall stock score, highlighting the need for strategic improvements.

To see Spark’s full report on TSE:PHA stock, click here.

More about Premier Health of America Inc

Premier Health of America Inc. is a leading Canadian Healthtech company that provides outsourced healthcare services solutions to governments, companies, and individuals. Utilizing its proprietary LiPHe platform, the company aims to lead the digital transformation of the healthcare services sector, offering faster, more affordable, and accessible care.

Average Trading Volume: 40,055

Technical Sentiment Signal: Sell

Current Market Cap: C$2.22M

For an in-depth examination of PHA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1